|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 9/12/22 Healthtech Solutions, Inc./UT 8-K:3,9 9/06/22 11:221K Bollman Trisha M/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 26K 2: EX-10 Exhibit 10-A HTML 36K 6: R1 Cover HTML 40K 9: XML IDEA XML File -- Filing Summary XML 11K 7: XML XBRL Instance -- hltt8k_htm XML 14K 8: EXCEL IDEA Workbook of Financial Reports XLSX 8K 4: EX-101.LAB XBRL Labels -- hltt-20220906_lab XML 96K 5: EX-101.PRE XBRL Presentations -- hltt-20220906_pre XML 64K 3: EX-101.SCH XBRL Schema -- hltt-20220906 XSD 12K 10: JSON XBRL Instance as JSON Data -- MetaLinks 25± 33K 11: ZIP XBRL Zipped Folder -- 0001262463-22-000120-xbrl Zip 24K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________
______________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): i September 6, 2022
______________
i HEALTHTECH SOLUTIONS, INC./UT
(Exact name of registrant as specified in its charter)
______________
| i Utah | i 0-51012 | i 84-2528660 |
| (State or Other Jurisdiction | (Commission | (I.R.S. Employer |
| of Incorporation) | File Number) | Identification No.) |
i 181 Dante Avenue, i Tuckahoe, i New York i 10707
(Address of Principal Executive Office) (Zip Code)
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
i ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
i ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
i ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
i ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
C:| C: 1 |
| ITEM 3.02 | UNREGISTERED SALE OF EQUITY SECURITIES |
On September 6, 2022 the Registrant’s Board of Directors approved a grant of options to purchase up to 15,000,000 shares of the Registrant’s common stock. The options were issued in compensation for the non-interest-bearing loans made by several of the Registrant’s shareholders to the Registrant during the past twelve months, which exceeded $1,500,000 and which remain outstanding. By agreement among the lenders, the options were issued to Storm Funding, LLC.
The options may be exercised during the next three years to purchase shares of the common stock for $0.25 per share, although the holder may not at any time exercise the options to purchase a number of shares that, when combined with all shares owned by the holder and its affiliates, would exceed 4.99% of the Registrant’s outstanding shares. Payment for the shares may be made in cash of by cashless exercise.
| ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS |
Exhibits
| 10-a | Common Stock Purchase Warrant dated September 6, 2022 issued to Storm Funding, LLC.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
| Healthtech Solutions, Inc. | ||
|
Date: September 12, 2022 |
By: |
Manuel E. Iglesias, President |
C:
| 2 |
C:
| This ‘8-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 9/12/22 | None on these Dates | ||
| For Period end: | 9/6/22 | |||
| List all Filings | ||||